Urgent Care /Primary Care
Dr. Elyse Watkins, DHSc, PA-C, DFAAPA
Purpose: This article aims to review the current role of bariatric surgery in the remission of diabetes and associated microvascular changes to reduce mortality, disability, socioeconomic burden, and obtain favorable outcomes.
Method: A PubMed literature search with search terms bariatric surgery, diabetes remission, and microvascular changes was conducted. Eleven pertinent articles were utilized as the basis for this clinical review.
Results: Despite advances in pharmaceutical regimens in the management of diabetes, the outcome has not significantly changed. About 463 million people worldwide have diabetes, of which 90% are type 2 diabetic.1 Obesity is the most vital modifiable risk factor for type 2 diabetes. High body mass index is linked with increased rates of type 2 diabetes, high blood pressure, gastroesophageal reflux, and certain types of cancer. Both obesity and diabetes are related to increased mortality risk, especially from cardiovascular disease. Bariatric surgery has been proven to significantly improve and sometimes induce remission of diabetes among morbidly obese diabetic patients.
Conclusion: A bariatric surgery offers an opportunity to better understand and treat the pathophysiology of type 2 diabetes. Bariatric surgery leads to changes in gastrointestinal anatomy which results in improved treatment of obesity and associated comorbidities.1
Rashad AA. The Impact of Bariatric Surgery on the Remission of Diabetes and Microvascular Changes, a Review. Lynchburg Journal of Medical Science. 2022; 4(3).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.